JUPITER NEUROSCIENCES, INC.
Extracted from this filing and checked against the source text.
JUPITER NEUROSCIENCES, INC. entered into Placement Agent Agreement with D. Boral Capital LLC valued at 7.0% of the gross proceeds (effective 2026-05-20).
On May 20, 2026, the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with D. Boral Capital LLC (“D. Boral”) pursuant to which the Company engaged D. Boral as the placement agent (the “Placement Agent”) in connection with the Offering.View on SEC.gov
JUPITER NEUROSCIENCES, INC. entered into Securities Purchase Agreement with the investors named therein valued at approximately $2.0 million (effective 2026-05-20).
On May 20, 2026, Jupiter Neurosciences, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the investors named therein (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the “Offering”), 7,142,858 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”), at a price of $0.28 per share, for aggregate gross proceeds to the Company of approximately $2.0 million before deducting the placement agent’s fees and related offering expenses.View on SEC.gov
38 material agreements filed in the last 30 days. Browse all material agreements →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.